Medical News

RSS

Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations

Older adults at risk for falls are less likely to suffer fall-related hospitalizations when they have a "fall plan of care," according to new research featuring faculty at Binghamton University, State University at New York.

25 Sep 2018

Lancaster professor aims to understand how genes affect smoking cessation

The Canadian Institute of Health Research has awarded $929,475 to Professor Jo Knight of Lancaster Medical School, Lancaster Data Science Institute and the Department of Psychiatry at the University of Toronto.

25 Sep 2018

Human-oriented perspective needed to better understand Parkinson's disease

Analysis published in Drug Discovery Today reveals the gap between animal models of Parkinson's disease and our understanding of the neurodegenerative processes underlying the disease, and calls for the implementation of modern, human biology-based technologies to better understand pathological processes and improve treatment outcome.

25 Sep 2018

Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear

About one decade after its first benefit assessment of negative pressure wound therapy, the German Institute for Quality and Efficiency in Health Care is reassessing this treatment method. However, then as now, its benefit and harm are unclear.

25 Sep 2018

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.

25 Sep 2018

Clinical trial investigators found non-compliant with requirement to report results on EU register

According to EU legislation, clinical trials must be prospectively registered in the European Union Clinical Trials Register and the main results must be reported there one year after completion of the trial. This information is thus publicly available.

25 Sep 2018

Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility

This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.

25 Sep 2018

Fracture causes bone density losses throughout the body

Breaking a bone causes bone density losses throughout the body, not just close to the site of the fracture, and primarily around the time of the fracture, two new studies from UC Davis Health show.

25 Sep 2018

Harmful H. pylori may play a role in Parkinson's disease

While human genetic mutations are involved in a small number of Parkinson's disease (PD) cases, the vast majority of cases are of unknown environmental causes, prompting enormous interest in identifying environmental risk factors involved.

25 Sep 2018

Your Vision Matters: How to Protect Your Eyesight

Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.

24 Sep 2018

Lung cancer patients treated with invasive surgery more likely to become chronic opioid users

Patients treated with more-invasive surgical techniques for a type of early-stage lung cancer are more likely to become chronic opioid users than patients treated with minimally invasive surgery, highlighting the need for additional research into how pain management after surgery might be a contributing factor to the opioid addiction crisis, according to a study published in JAMA Oncology in September.

24 Sep 2018

Study sheds light on how brain protein may be involved neurodevelopmental disorders

A study by researchers at Rockefeller University has shown that defects in a brain protein may underlie a number of neurodevelopmental disorders.

24 Sep 2018

TU Wien develops new remedy for celiac disease

Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.

24 Sep 2018

Gene therapy approach could help treat mitochondrial diseases

Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

24 Sep 2018

Using multi-level approach to reduce underage drinking among youths on rural reservations

Underage drinking is a concern all over the country. Among American Indian and Alaska Native populations, there are especially serious issues: alcohol use and heavy drinking at an early age increase risks for lifetime alcohol problems, and American Indians and Native Alaskans have reported younger onsets than other groups.

24 Sep 2018

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Kessler Foundation researchers have published their findings linking behavioral symptoms with employment outcomes among adults with moderate to severe traumatic brain injury.

24 Sep 2018

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced positive clinical data from the company's recently expanded U.S. early feasibility study evaluating the safety of the investigational AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation.

24 Sep 2018

Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US

Gilead Sciences, Inc. announced today plans to launch authorized generic versions of Epclusa and Harvoni, Gilead's leading treatments for chronic hepatitis C virus, in the United States, through a newly created subsidiary, Asegua Therapeutics LLC.

24 Sep 2018

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.

24 Sep 2018

Vanteres announces new evidence demonstrating role of LPC-DHA in fetal brain development

Vanteres, an innovative biotech company leveraging its biomedical research expertise to develop actively transported lysophospholipids, announces new evidence that demonstrates the critical role of LPC-DHA in normal fetal and infant brain development.

24 Sep 2018

Medical News

Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations

Lancaster professor aims to understand how genes affect smoking cessation

Human-oriented perspective needed to better understand Parkinson's disease

Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Clinical trial investigators found non-compliant with requirement to report results on EU register

Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility

Fracture causes bone density losses throughout the body

Harmful H. pylori may play a role in Parkinson's disease

Your Vision Matters: How to Protect Your Eyesight

Lung cancer patients treated with invasive surgery more likely to become chronic opioid users

Study sheds light on how brain protein may be involved neurodevelopmental disorders

TU Wien develops new remedy for celiac disease

Gene therapy approach could help treat mitochondrial diseases

Using multi-level approach to reduce underage drinking among youths on rural reservations

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Vanteres announces new evidence demonstrating role of LPC-DHA in fetal brain development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News